765 related articles for article (PubMed ID: 15570636)
1. Therapeutic strategies in rheumatoid arthritis over a 40-year period.
Kremers HM; Nicola P; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2004 Dec; 31(12):2366-73. PubMed ID: 15570636
[TBL] [Abstract][Full Text] [Related]
2. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
[TBL] [Abstract][Full Text] [Related]
3. Contemporary use of disease-modifying drugs in the management of patients with early rheumatoid arthritis in Norway.
Nikolaisen C; Kvien TK; Mikkelsen K; Kaufmann C; Rødevand E; Nossent JC
Scand J Rheumatol; 2009; 38(4):240-5. PubMed ID: 19229766
[TBL] [Abstract][Full Text] [Related]
4. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years.
Gabriel SE; Crowson CS; Kremers HM; Doran MF; Turesson C; O'Fallon WM; Matteson EL
Arthritis Rheum; 2003 Jan; 48(1):54-8. PubMed ID: 12528103
[TBL] [Abstract][Full Text] [Related]
5. The widening mortality gap between rheumatoid arthritis patients and the general population.
Gonzalez A; Maradit Kremers H; Crowson CS; Nicola PJ; Davis JM; Therneau TM; Roger VL; Gabriel SE
Arthritis Rheum; 2007 Nov; 56(11):3583-7. PubMed ID: 17968923
[TBL] [Abstract][Full Text] [Related]
6. "5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapy.
Capell H; McCarey D; Madhok R; Hampson R
J Rheumatol; 2002 Oct; 29(10):2099-105. PubMed ID: 12375318
[TBL] [Abstract][Full Text] [Related]
7. Population-based mortality outcome of rheumatoid arthritis in females.
Iacovino JR
J Insur Med; 2002; 34(2):86-8. PubMed ID: 15305782
[TBL] [Abstract][Full Text] [Related]
8. Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis.
Hernández-García C; Vargas E; Abásolo L; Lajas C; Bellajdell B; Morado IC; Macarrón P; Pato E; Fernández-Gutiérrez B; Bañares A; Jover JA
J Rheumatol; 2000 Oct; 27(10):2323-8. PubMed ID: 11036824
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular death in rheumatoid arthritis: a population-based study.
Maradit-Kremers H; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
Arthritis Rheum; 2005 Mar; 52(3):722-32. PubMed ID: 15751097
[TBL] [Abstract][Full Text] [Related]
10. Disappointing longterm results with disease modifying antirheumatic drugs. A practice based study.
Galindo-Rodriguez G; Aviña-Zubieta JA; Russell AS; Suarez-Almazor ME
J Rheumatol; 1999 Nov; 26(11):2337-43. PubMed ID: 10555887
[TBL] [Abstract][Full Text] [Related]
11. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years.
Nicola PJ; Maradit-Kremers H; Roger VL; Jacobsen SJ; Crowson CS; Ballman KV; Gabriel SE
Arthritis Rheum; 2005 Feb; 52(2):412-20. PubMed ID: 15692992
[TBL] [Abstract][Full Text] [Related]
12. Time to methotrexate treatment in patients with rheumatoid arthritis referred to hospital.
de Thurah A; Nørgaard M; Johansen M; Stengaard-Pedersen K
Scand J Rheumatol; 2010; 39(1):19-25. PubMed ID: 20132066
[TBL] [Abstract][Full Text] [Related]
13. Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry.
Weaver AL; Lautzenheiser RL; Schiff MH; Gibofsky A; Perruquet JL; Luetkemeyer J; Paulus HE; Xia HA; Leff JA;
Curr Med Res Opin; 2006 Jan; 22(1):185-98. PubMed ID: 16393444
[TBL] [Abstract][Full Text] [Related]
14. Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis.
Kremers HM; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
Arthritis Rheum; 2004 Nov; 50(11):3450-7. PubMed ID: 15529378
[TBL] [Abstract][Full Text] [Related]
15. Mortality in rheumatoid arthritis: have we made an impact in 4 decades?
Gabriel SE; Crowson CS; O'Fallon WM
J Rheumatol; 1999 Dec; 26(12):2529-33. PubMed ID: 10606358
[TBL] [Abstract][Full Text] [Related]
16. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T;
Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
[TBL] [Abstract][Full Text] [Related]
17. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.
Nikolaisen C; Rekvig OP; Nossent HC
Scand J Rheumatol; 2005; 34(4):269-76. PubMed ID: 16195159
[TBL] [Abstract][Full Text] [Related]
18. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
Maradit-Kremers H; Crowson CS; Nicola PJ; Ballman KV; Roger VL; Jacobsen SJ; Gabriel SE
Arthritis Rheum; 2005 Feb; 52(2):402-11. PubMed ID: 15693010
[TBL] [Abstract][Full Text] [Related]
19. Patterns of drug use in rheumatoid arthritis.
Bérard A; Solomon DH; Avorn J
J Rheumatol; 2000 Jul; 27(7):1648-55. PubMed ID: 10914846
[TBL] [Abstract][Full Text] [Related]
20. Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis.
Gonzalez-Alvaro I; Carmona L; Balsa A; Sanmarti R; Belmonte MA; Tena X;
J Rheumatol; 2003 Apr; 30(4):697-704. PubMed ID: 12672186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
